Beam
Molly (Magill) James currently serves as the Associate Director of Strategic Sourcing at Beam Therapeutics, a role started in May 2023. Prior experience includes serving as Senior Manager of R&D Strategic Sourcing at Alexion Pharmaceuticals, Inc. from September 2019 to June 2023, and holding positions as Outsourcing Lead and Outsourcing Specialist at Takeda Oncology between April 2014 and September 2019, where responsibilities included managing clinical contracts and achieving cost savings. Earlier career roles included Budget Planner at ReSearch Pharmaceutical Services and Clinical Contracts and Vendor Management Coordinator at AVEO Pharmaceuticals, where management of trial budgets and negotiation of clinical agreements were key duties. Education includes a Master of Business Administration in Health Care Administration from UMass Boston and a Bachelor of Science in Marketing and Communications from Bryant University.
This person is not in any teams
This person is not in any offices
Beam
10 followers
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines.